HarmonEyes Completes Acquisition of iFocus Health

Published on December 11, 2025
BETHESDA, Md.—HarmonEyes, an AI-driven eye-tracking software company, has announced the acquisition of iFocus Health, a clinically validated ADHD treatment monitoring solution that tracks eye movement to objectively assess patient response to medication. The iFocus platform addresses what has long been a challenge in ADHD care: the lack of reliable, real-time biomarkers to determine how well a treatment works, HarmonEyes said. By tracking subtle changes in eye movement during everyday activities like reading, iFocus provides clinicians with objective and actionable data, allowing for a more personalized and precise approach to care, the announcement noted.